Kakehi Y, Yoshida O
Department of Urology, Kyoto University Faculty of Medicine, Japan.
Int J Cancer. 1989 Mar 15;43(3):391-4. doi: 10.1002/ijc.2910430307.
We examined Southern blot analyses of normal and tumor DNAs from 50 patients with sporadic renal cancer, using the human L-myc oncogene fragment as a hybridization probe. Our purpose was to study the relationship between the restriction fragment length polymorphism (RFLP) of the L-myc and the frequencies of metastases. There was no individual difference in patterns of L-myc RFLP between normal and tumor-tissue DNAs digested with EcoRI. The patients were classified into 3 genetic types according to the polymorphic patterns defined by the 2 alleles [10-kilobase (kb) and 6.6-kb fragments]. The relative ratios of the 3 genotypes in the renal cancer patients were similar to those seen in healthy Japanese. However, of 16 patients who exhibited distant organ metastases at the time of surgery, only one was a 10-kb fragment homozygote. The incidence of distant metastases in 10-kb homozygotes was significantly lower than that in 6.6-kb homozygotes plus heterozygotes (p = 0.06). These results basically correspond to the previous findings in the lung cancer patients, and suggest that L-myc RFLP is a widely applicable genetic marker to predict prognosis in cancer patients.
我们使用人L-myc癌基因片段作为杂交探针,对50例散发性肾癌患者的正常DNA和肿瘤DNA进行了Southern印迹分析。我们的目的是研究L-myc的限制性片段长度多态性(RFLP)与转移频率之间的关系。用EcoRI消化的正常和肿瘤组织DNA之间,L-myc RFLP模式没有个体差异。根据由两个等位基因(10千碱基(kb)和6.6-kb片段)定义的多态性模式,将患者分为3种遗传类型。肾癌患者中3种基因型的相对比例与健康日本人中的相似。然而,在手术时出现远处器官转移的16例患者中,只有1例是10-kb片段纯合子。10-kb纯合子中远处转移的发生率显著低于6.6-kb纯合子加杂合子中的发生率(p = 0.06)。这些结果基本与先前在肺癌患者中的发现一致,并表明L-myc RFLP是一种广泛适用的遗传标记,可用于预测癌症患者的预后。